Quantitation of HTLV-I proviral load by a real-time PCR assay using SYBR Green: Comparison of two methods for DNA isolation

Journal of Virological Methods

Volumn 170, Issue 1-2, 2010, Pages 160-164

  Altamirano, Natalia Andrea ^a   Rocco, Carlos ^a   Aulicino, Paula ^a   Sen, Luisa ^a   Mangano, Andrea ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

HTLV I; Proviral load; Real time quantitative PCR; SYBR Green

Indexed keywords

ALBUMIN; CELL DNA; DYE; SYBR GREEN; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; BLOOD DONOR; CELL LYSATE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS REACTION; DNA ISOLATION; FISHER EXACT TEST; GENE DOSAGE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; LYMPHOBLASTOID CELL LINE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROVIRUS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STRUCTURAL GENE; VIRUS LOAD;

CELL LINE; DNA PRIMERS; DNA, VIRAL; GENES, POL; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKOCYTES, MONONUCLEAR; ORGANIC CHEMICALS; POLYMERASE CHAIN REACTION; PROVIRUSES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 78249253039     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.08.021     Document Type: Article

References (27)

1. Besson G., Kazanji M. One-step, multiplex, real-time PCR assay with molecular beacon probes for simultaneous detection, differentiation, and quantification of human T-cell leukemia virus types 1, 2, and 3. J. Clin. Microbiol. 2009, 47(4):1129-1135.
2. Biglione M.M., Pizarro M., Puca A., Salomón H.E., Berría M.I. A cluster of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Jujuy, Argentina. J. Acquir. Immune Defic. Syndr. 2003, 32(4):441-445.
3. Bouzas M.B., Muchinik G.R., Zapiola I., De Rosa M.F., Perez Bianco R., Pimentel E., Dengra C., Del Pino N., Gallo D., Hanson C.V. Prevalence of HTLV-I/II among blood bank donors in Argentina. J. Acquir. Immune Defic. Syndr. 1992, 5(12):1275-1276.
4. Bouzas M.B., Zapiola I., Quiruelas S., Gorvein D., Panzita A., Rey J., Carnese F.P., Corral R., Perez C., Zala C., Gallo D., Hanson C.V., Muchinik G. HTLV type I and HTLV type II infection among Indians and natives from Argentina. AIDS Res. Hum. Retroviruses 1994, 10(11):1567-1571.
5. Carneiro-Proietti A.B., Catalan-Soares B.C., Castro-Costa C.M., Murphy E.L., Sabino E.C., Hisada M., Galvão-Castro B., Alcantara L.C., Remondegui C., Verdonck K., Proietti F.A. HTLV in the Americas: challenges and perspectives. Rev. Panam. Salud Pública 2006, 19(1):44-53. (Review).
6. Cler L., Bu D., Lewis C., Euhus D. A comparison of five methods for extracting DNA from paucicellular clinical samples. Mol. Cell. Probes 2006, 20(3-4):191-196.
7. Dehée A., Césaire R., Désiré N., Lézin A., Bourdonné O., Béra O., Plumelle Y., Smadja D., Nicolas J.C. Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J. Virol. Methods 2002, 102(1-2):37-51.
8. Gastaldello R., Hall W.W., Gallego S. Seroepidemiology of HTLV-I/II in Argentina: an overview. J. Acquir. Immune Defic. Syndr. 2004, 35(3):301-308. (Review).
9. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2(8452):407-410.
10. Iwanaga M., Watanabe T., Utsunomiya A., Okayama A., Uchimaru K., Koh K.R., Ogata M., Kikuchi H., Sagara Y., Uozumi K., Mochizuki M., Tsukasaki K., Saburi Y., Yamamura M., Tanaka J., Moriuchi Y., Hino S., Kamihira S., Yamaguchi K. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 2010, (Epub ahead of print).
11. Kamihira S., Dateki N., Sugahara K., Hayashi T., Harasawa H., Minami S., Hirakata Y., Yamada Y. Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. Clin. Lab. Haematol. 2003, 25(2):111-117.
12. Kobayashi N., Konishi H., Sabe H., Shigesada K., Noma T., Honjo T., Hatanaka M. Genomic structure of HTLV (human T-cell leukemia virus): detection of defective genome and its amplification in MT2 cells. EMBO J. 1984, 3(6):1339-1343.
13. Lee T.H., Chafets D.M., Busch M.P., Murphy E.L. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J. Clin. Virol. 2004, 31(4):275-282.
14. Mangano A.M., Remesar M., del Pozo A., Sen L. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns. J. Med. Virol. 2004, 74(2):323-327.
15. Miley W.J., Suryanarayana K., Manns A., Kubota R., Jacobson S., Lifson J.D., Waters D. Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load. AIDS Res. Hum. Retroviruses 2000, 16(7):665-675.
16. Moens B., López G., Adaui V., González E., Kerremans L., Clark D., Verdonck K., Gotuzzo E., Vanham G., Cassar O., Gessain A., Vandamme A.M., Van Dooren S. Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination. J. Clin. Microbiol. 2009, 47(11):3682-3691.
17. Olindo S., Lézin A., Cabre P., Merle H., Saint-Vil M., Edimonana Kaptue M., Signate A., Césaire R., Smadja D. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression. J. Neurol. Sci. 2005, 237(1-2):53-59.
18. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U.S.A. 1980, 77(12):7415-7419.
19. Pongers Willemse M.J., Verhagen O.J., Tibbe G.J., Wijkhuijs A.J., de Haas V., Roovers E., van der Schoot C.E., van Dongen J.J. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia 1998, 12(12):2006-2014.
20. Primo J., Siqueira I., Nascimento M.C., Oliveira M.F., Farre L., Carvalho E.M., Bittencourt A.L. High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1. Braz. J. Med. Biol. Res. 2009, 42(8):761-764.
21. Proietti F.A., Carneiro Proietti A.B., Catalan Soares B.C., Murphy E.L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 24(39):6058-6068. (Review).
22. Remesar M., Mangano A., Sen L., del Pozo A. Profile of human T-cell lymphocytotrophic virus-I/II infections in an Argentinean blood bank population. Vox Sang. 2002, 83(4):364-365.
23. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory Press, New York. 2nd ed.
24. Sasaki D., Doi Y., Hasegawa H., Yanagihara K., Tsukasaki K., Iwanaga M., Yamada Y., Watanabe T., Kamihira S. High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders. Virol. J. 2010, 7:81-88.
25. Silva M.T., Harab R.C., Leite A.C., Schor D., Araújo A., Andrada-Serpa M.J. Human T lymphotropic virus type I (HTLV-I) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-I infection. Clin. Infect. Dis. 2007, 44(5):689-692.
26. Vallejo A., García-Sáis A. Typing human T-cell lymphotropic virus (HTLV-I and HTLV-II) by nested polymerase chain reaction: application to clinical specimens. J. Virol. Methods 1995, 51(1):9-18.
27. Vitone F., Gibellini D., Schiavone P., D'Antuono A., Gianni L., Bon I., Re M.C. Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results. BMC Infect. Dis. 2006, 6:41-49.